SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward W. Richmond who wrote (278)6/27/1998 3:03:00 PM
From: Garry K.  Read Replies (1) of 572
 
Hi Edward,

I can relate with your frustration, as I have held Xillix for about the same time period. I wanted to attend the AGM but was unable to make the trip due to work commitments. I was wondering if you could highlight some of the major discussion that went on at the meeting.

With the price of Xillix under $2.00CDN I will continue accumulating the stock, as I feel it is undervalued, unfollowed, and on the threshhold of making the transition from a R & D Company, to becoming a commercial player in the medical diagnostics field. This of course will not happen overnight as we have seen, but I would rather take my position in this company now and continue accumulating while the fundamentals continue to improve, than to buy when the investment community begins to take notice. Patience and discipline is certainly paramount when it comes to these kind of companies. Accepting the risk is also an important consideration.

If you have any additional comments Edward, I would certainly like to hear from you. Good luck!

Regards,

Garry

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext